| claim |
grand-strategy |
Cross-domain evidence from pharmaceutical governance (1906-1962) and arms control (ICBL) independently confirms the same three-component mechanism |
likely |
FDA regulatory history (sulfanilamide 1937, thalidomide 1961), ICBL case from Session 2026-03-31 |
2026-04-01 |
| extractor |
sourcer |
|
|
| handle |
context |
| leo |
FDA regulatory history (sulfanilamide 1937, thalidomide 1961), ICBL case from Session 2026-03-31 |
|
|
|
| pharmaceutical-governance-advances-required-triggering-events-not-incremental-advocacy-because-kefauver-three-year-blockage-preceded-thalidomide-breakthrough |
| pharmaceutical-governance-advances-required-triggering-events-not-incremental-advocacy-because-kefauver-three-year-blockage-proves-technical-expertise-insufficient |
| triggering-event-architecture-requires-three-components-infrastructure-disaster-champion-as-confirmed-by-pharmaceutical-and-arms-control-cases |
|
| pharmaceutical-governance-advances-required-triggering-events-not-incremental-advocacy-because-kefauver-three-year-blockage-preceded-thalidomide-breakthrough|supports|2026-04-19 |
| pharmaceutical-governance-advances-required-triggering-events-not-incremental-advocacy-because-kefauver-three-year-blockage-proves-technical-expertise-insufficient|supports|2026-04-19 |
| triggering-event-architecture-requires-three-components-infrastructure-disaster-champion-as-confirmed-by-pharmaceutical-and-arms-control-cases|supports|2026-04-20 |
| Weapons stigmatization campaigns require triggering events with four properties: attribution clarity, visibility, emotional resonance, and victimhood asymmetry|related|2026-04-20 |
|
| weapons-stigmatization-campaigns-require-triggering-events-with-four-properties-attribution-clarity-visibility-emotional-resonance-and-victimhood-asymmetry |
|